Healthcare provider profile · identity verified

Cecilio Hernandez Latorre, MD

General Practice · SAN JUAN, PR · NPI 1265441307

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	639	125
Levothyroxine Sodium	Levothyroxine Sodium	518	96
Losartan Potassium	Losartan Potassium	360	85
Famotidine	Famotidine	336	76
Gabapentin	Gabapentin	329	74
Sertraline Hcl	Sertraline Hcl	292	52
Amlodipine Besylate	Amlodipine Besylate	279	60
Donepezil Hcl	Donepezil Hcl	277	51
Buspirone Hcl	Buspirone Hcl	265	46
Simvastatin	Simvastatin	261	55
Memantine Hcl	Memantine Hcl	260	45
Clonazepam	Clonazepam	257	42
Metformin Hcl	Metformin Hcl	241	54
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	237	97
Pantoprazole Sodium	Pantoprazole Sodium	226	50
Temazepam	Temazepam	218	39
Trazodone Hcl	Trazodone Hcl	206	42
Clopidogrel	Clopidogrel Bisulfate	200	43
Metoprolol Succinate	Metoprolol Succinate	151	34
Omeprazole	Omeprazole	147	28
Rosuvastatin Calcium	Rosuvastatin Calcium	145	26
Quetiapine Fumarate	Quetiapine Fumarate	141	28
Synthroid	Levothyroxine Sodium	141	36
Lorazepam	Lorazepam	135	18
Levetiracetam	Levetiracetam	133	24
Lisinopril	Lisinopril	133	37
Mirtazapine	Mirtazapine	125	14
Furosemide	Furosemide	124	26
Risperidone	Risperidone	119	23
Tamsulosin Hcl	Tamsulosin Hcl	119	21
Alprazolam	Alprazolam	108	18
Montelukast Sodium	Montelukast Sodium	98	22
Olanzapine	Olanzapine	98	17
Metoprolol Tartrate	Metoprolol Tartrate	95	19
Hydrochlorothiazide	Hydrochlorothiazide	94	21
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	93	77
Prednisone	Prednisone	80	43
Levofloxacin	Levofloxacin	77	60
Carbidopa-Levodopa	Carbidopa/Levodopa	74	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	65	47
Alendronate Sodium	Alendronate Sodium	63	12
Enalapril Maleate	Enalapril Maleate	63	14
Carvedilol	Carvedilol	61	15
Citalopram Hbr	Citalopram Hydrobromide	61	suppressed
Mupirocin	Mupirocin	60	35
Lantus	Insulin Glargine,hum.Rec.Anlog	58	13
Eliquis	Apixaban	55	13
Xarelto	Rivaroxaban	55	14
Glimepiride	Glimepiride	50	13
Glipizide Er	Glipizide	49	12
Potassium Chloride	Potassium Chloride	49	suppressed
Atenolol	Atenolol	48	suppressed
Hydralazine Hcl	Hydralazine Hcl	47	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	46	11
Bupropion Xl	Bupropion Hcl	44	suppressed
Nifedipine Er	Nifedipine	44	suppressed
Folic Acid	Folic Acid	43	suppressed
Divalproex Sodium	Divalproex Sodium	41	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	39	16
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	38	20
Aripiprazole	Aripiprazole	37	suppressed
Azithromycin	Azithromycin	37	29
Galantamine Er	Galantamine Hbr	37	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	37	suppressed
Ramipril	Ramipril	37	suppressed
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	36	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	36	35
Irbesartan	Irbesartan	36	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	suppressed
Permethrin	Permethrin	36	20
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	33	suppressed
Sucralfate	Sucralfate	33	suppressed
Allopurinol	Allopurinol	32	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	32	13
Cilostazol	Cilostazol	31	suppressed
Diclofenac Potassium	Diclofenac Potassium	31	16
Pravastatin Sodium	Pravastatin Sodium	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	30	suppressed
Memantine Hcl Er	Memantine Hcl	27	suppressed
Clonidine Hcl	Clonidine Hcl	26	suppressed
Glipizide	Glipizide	26	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	26	suppressed
Megestrol Acetate	Megestrol Acetate	26	suppressed
Spironolactone	Spironolactone	26	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	25	suppressed
Lactulose	Lactulose	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	12
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Primidone	Primidone	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Valsartan	Valsartan	24	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Anastrozole	Anastrozole	22	suppressed
Baclofen	Baclofen	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Ketoconazole	Ketoconazole	22	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Finasteride	Finasteride	20	suppressed
Sulfasalazine	Sulfasalazine	20	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Fluticasone Propionate	Fluticasone Propionate	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Pentoxifylline	Pentoxifylline	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Ssd	Silver Sulfadiazine	17	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Methylprednisolone	Methylprednisolone	16	12
Cholestyramine	Cholestyramine (With Sugar)	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	12
Timolol Maleate	Timolol Maleate	15	suppressed
Hydroxyurea	Hydroxyurea	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Lumigan	Bimatoprost	14	suppressed
Nabumetone	Nabumetone	14	suppressed
Raloxifene Hcl	Raloxifene Hcl	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Digoxin	Digoxin	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Propafenone Hcl	Propafenone Hcl	13	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	13	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Metoprolol-Hydrochlorothiazide	Metoprolol/Hydrochlorothiazide	12	suppressed
Bethanechol Chloride	Bethanechol Chloride	11	suppressed
Bicalutamide	Bicalutamide	11	suppressed
Celecoxib	Celecoxib	11	suppressed
Cholestyramine Light	Cholestyramine	11	suppressed
Galantamine Hbr	Galantamine Hbr	11	suppressed
Humalog	Insulin Lispro	11	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Rivastigmine	Rivastigmine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error